Related Experiment Video
Updated: Jul 4, 2026

09:57
Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Putting the spotlight on spot-on treatments
The Veterinary Record
|July 3, 2026
Summary
A parliamentary committee is examining the environmental effects of veterinary parasiticides. This investigation focuses on the impact of these common animal health treatments on ecosystems and biodiversity.
Area of Science:
- Veterinary Science
- Environmental Science
- Ecotoxicology
Background:
- Veterinary parasiticides are widely used to treat and prevent parasitic infections in animals.
- Concerns exist regarding the potential environmental consequences of widespread veterinary drug usage.
- The environmental impact of veterinary medicines is a growing area of scientific and regulatory interest.
Purpose of the Study:
- To discuss the ongoing investigation by a House of Lords select committee.
- To highlight the focus on the environmental impact of veterinary parasiticides.
- To inform stakeholders about the scope and significance of this parliamentary inquiry.
Main Methods:
- The abstract indicates a discussion format, likely involving a review of committee proceedings and expert consultations.
- Information is presented from the perspective of a parliamentary veterinary intern.
- The focus is on the investigative process rather than primary data collection.
Main Results:
- The House of Lords select committee is actively investigating the environmental impact of veterinary parasiticides.
- The investigation aims to understand the ecological effects associated with these treatments.
- Key findings and recommendations from the committee are anticipated.
Conclusions:
- The parliamentary review underscores the importance of assessing the environmental footprint of veterinary parasiticides.
- Further research and regulatory considerations are likely to emerge from this investigation.
- Responsible use and development of environmentally safer alternatives are crucial for sustainable animal health practices.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

